Moscow, Sep 22 (efe-epa).- Russia plans to vaccinate between 70 and 80 percent of its population against Covid-19 within nine to 12 months, its lead developer said Tuesday.
Alexander Ginzburg, director of the Gamaleya Research Institute of Epidemiology and Microbiology which is developing the vaccine, said the first batches have been distributed to all regions in Russia.
Gamaleya Center, creator of the first Russian anti-coronavirus vaccine, called Sputnik V.
He said in an online discussion that the priority is to increase the production of the drug.
He added that Gamaleya has employees working in three shifts but still cannot produce enough for Russia’s 144 million population and has delegated production to three or four other companies.
“By November of this year we estimate that we will produce five or six million vaccines,” Ginzburg said.
“We understand that this will allow us to vaccinate our population in the course of nine to 12 months and reach a level of vaccination in the order of 70 or 80 percent.”
That level of vaccination would stop the circulation of new coronavirus among the population, according to the expert.
Ginzburg said clinical studies are showing successful results.
“Some 2,500 Muscovites have already been inoculated with the first component of the vaccine, and they do not present any complications,” he added.